Fred Hutchinson Cancer Center and UW Medicine’s Endocrine Tumor Program (ETP) uses an integrated, multidisciplinary team approach to treating patients with thyroid cancer and other endocrine cancers and tumors. Your care team includes specialists in endocrinology, surgery, radiology, medical oncology, radiation oncology, nuclear medicine, pathology and other experts in treating patients with endocrine tumors.
Fred Hutch ETP is the largest, most experienced program of its kind in the Pacific Northwest. We offer a unique longitudinal care model — a coordinated, team-based approach to long-term care — with a specialized advanced practice provider, like a physician assistant (PA) or an advanced registered nurse practitioner (ARNP). We will guide you every step of the way, combining our deep clinical expertise with a commitment to meet your personal needs.
Fred Hutch and UW Medicine’s Endocrine Tumor Program (ETP) uses an integrated, multidisciplinary team approach to treating patients with thyroid cancer and other endocrine cancers. Your care team includes specialists in endocrinology, surgery, radiology, medical oncology, radiation oncology, nuclear medicine, pathology and other experts in treating patients with thyroid cancer and other endocrine cancers and tumors.
To give you access to the latest endocrine tumor treatments, we bring together the leading researchers and cancer specialists of Fred Hutch and UW Medicine so you can join clinical studies that are not available everywhere. View Clinical Trials
Fred Hutch Endocrinology Tumor Program provides longitudinal care — a coordinated, team-based approach to long-term care — to patients who have been treated here. This means we will continue to see you after your cancer treatment is over. The program includes three endocrinologists with special training in oncology as well as an advanced registered nurse practitioner (ARNP). Learn more about LTFU
Fred Hutch is the leading cancer treatment center in the region. Our program helps update National Comprehensive Care Center (NCCN) guidelines, and we bring all of the latest changes and newly-approved therapies into our own patient care.
Our services include initial diagnosis, treatment and ongoing management of thyroid, parathyroid and adrenal gland nodules, masses, cancers and other conditions. We also offer fine needle aspiration (biopsy), molecular diagnostics and surgical options. Your treatment plan will depend on your exact diagnosis.
Fred Hutch has molecular imaging and therapy specialists who can do whole-body dosimetry, measure iodine absorption and make safer dose decisions for patients with complicated conditions or metastatic cancer. We also have 68Ga-DOTATATE radiotracers for metastatic neuroendocrine tumor evaluation.
Our program follows pathways based on the latest guidelines by the American Thyroid Association and the National Comprehensive Care Network (NCCN).
At Fred Hutch, a team of dedicated people surrounds you and your family to give you the highest level of care and support. You are the most important person on your care team. Our patients are at the center of everything we do.
Many common cancer treatments, like immunotherapy, can affect a patient’s endocrine system, even if the primary cancer treated was not an endocrine cancer. Tumors or long-term side effects on the endocrine system can cause changes to sleep, digestion and other body functions. Sometimes these effects go on for several years, long after the active phase of cancer treatment is over. Also, people who have been treated for a thyroid malignancy may need long-term monitoring in case their thyroid cancer comes back (a recurrence).
For these groups of people, our program offers long-term follow-up care, where you can meet with an endocrinologist to make a long-term plan.
We offer care to patients who have been treated at Fred Hutch. The program includes three endocrinologists who specialize in oncology and an advanced registered nurse practitioner (ARNP).
Our dedicated endocrinology nurse practitioner will provide ongoing surveillance for thyroid cancer patients and manage endocrine-related side effects from cancer treatment. During your appointment, we will review any labs and imaging related to your cancer and treatment and discuss how you are feeling on your medications and make changes if necessary. You will receive an annual follow-up visit at a minimum, and your care team is always available for an appointment sooner for any questions or concerns that come up between appointments.
— Katherine Parikh, ARNP